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EVIDENCE-BASED PRACTICE CONSIDERATIONS IN
FACILITATING THE RISK SURVEILLANCE OF
OCCUPATIONAL EXPOSURE TO
ANTINEOPLASTIC AGENTS
Theresa Rafique, MSN, RN
Mississippi University for Women
Supervising Professor: Dr. Janice Unruh Davidson
Abstract
According to Martin and Larson (2003), healthcare professionals involved with
handling antineoplastic drugs may be exposed inadvertently to these agents, placing them
at potential risk for acute and long-term adverse effects. For example, cyclophosphamide
one of the most frequently used antineoplastic agents in clinical treatment facilities, is a
known human carcinogen (Larson, Khazaeli, & Dillon, 2003). While the health risks
associated with cytotoxic use have been well established, there is little information
available about how people perceive these risks, particularly among those most affected
by it-chemotherapy nurses. Therefore, the purpose of this Evidence Based Practice (EBP)
project was to develop a nurse practitioner knowledgebase regarding the impact of risk
perception on the cytotoxic agent safety behaviors of oncology nurses. The research
questions asked: (a) what is the level of healthcare knowledge regarding the role of the
healthcare provider in facilitating risk surveillance of occupational exposure to
antineoplastic agents? (b) according to the literature, how can healthcare providers
contribute to cost-effective, high-quality care by facilitating risk surveillance of
occupational hazards? and (c) according to the literature, how can healthcare providers

contribute to cost-effective, high-quality care by facilitating risk surveillance of exposure
to antineoplastic agents? A Boolean computer search of nursing and medical literature
for theory-based, data-based, randomized controlled trials for citations utilizing
CINAHL, MEDLINE, and the Cochrane Library was conducted for this systematic
review.
Becker’s Health Belief Model (1974) served as the theoretical foundation for this
clinical project and guided the systematic review through data collection of the healthcare
literature. Literature reviewed totaled 8 manuscripts, which represented reviews of
another 122 references. Studies o f healthcare workers have shown that occupational
exposure to antineoplastic agents has caused acute adverse effects such as nausea,
headache and dizziness (Valanis, Vollmer, Labuhn, & Glass, 1997). Exposure risk and its
relationship to healthcare professionals’ compliance to established protocols for the safe
handling and administration of chemotherapy agents continues to be a concern for health
care institutions (Ritchie, McAdams, & Fritz, 2000). The literature reviewed for this
study recommends compliance with established safety guidelines to ensure adequate
protection to those involved in the handling, administration, and care of patients receiving
antineoplastic agents. Yet despite the adoption of these guidelines in healthcare
institutions, the current literature also suggests that many workers do not follow the
standards established by their employers and current OSHA guidelines, putting
themselves at risk for exposure to potential mutagenicity, alterations in fertility and long
term effects from chemotherapy agents (Valanis, Vollmer, Labuhn, & Glass, 1997).
Using an Evidence Based Medicine (EBM) approach, based on that of Sackett,
Straus, Richardson, Rosenberg, and Haynes (2000), a knowledgebase was developed
vi

according to methods described by Davidson (2003) in which key findings from the
systematic review of randomized control trials, data-based and theory-based literature
were compared with current practice guidelines, resulting in a number of safe practice
recommendations. These recommendations emphasize that safe levels of exposure to
antineoplastic agents have not been determined therefore; it is essential to minimize
exposure.
The need for fiirther attention to risk surveillance of occupational exposure to
antineoplastics in advanced practice nursing literature is critical. Evidence-based practice
modalities that will utilize current guidelines in the risk surveillance of occupational
exposure to antineoplastic agents are essential for nurse practitioner application in
oncology settings. Implications for nursing theory, nursing research, advanced nursing
practice, nurse practitioner education, and health policy are provided as they emerge from
the concepts explored.
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CHAPTER I
Dimensions of the Problem
Occupational exposure to harmtiil agents has been identified as a problem of
increasing health concern (Martin & Larson, 2003). Agencies such as the Oncology
Nursing Society, the Occupational Safety and Health Administration, and the American
Society of Health-Systems Pharmacists have developed guidelines for the safe handling
of hazardous drugs because of the potential dangers they present. According to Martin
and Larson, compliance with established safety guidelines is increasing as compared to
previous chemotherapy-handling studies. However, many health professionals continue
to disregard these guidelines in their everyday practice.
The administration of chemotherapeutic agents is an integral part of nurses’ role
in the provision of care. Cytostatic drugs possess toxic properties and may cause
mutagenic, carcinogenic and teratogenic effects. Therefore, nurses handling these drugs
in the course of their profession may face serious health risks. The occupational exposure
risk of cytotoxic agents was first documented in healthcare personnel by Falck et al.
(1979), who reported an elevated frequency of mutagenesis in spot urines after
continuous low-level exposure within a group of oncology nurses. Proper handling of
these drugs combined with the use of personal protective equipment can drastically
reduce this threat.
Problem Statement
While the health risks associated with cytotoxic use have been well established,
there is little information available about how people perceive these risks, particularly
among those most affected by it-chemotherapy nurses. Chemotherapy is a treatment
1

method of choice for many cancers. The preparation and administration of
chemotherapeutic agents is often a primary responsibility of the oncology nurse.
According to Martin and Larson (2003), healthcare professionals involved with handling
antineoplastic drugs may be exposed inadvertently to these agents, placing them at
potential risk for acute and long-term adverse effects. For example, cyclophosphamide is
one of the most fi-equently used antineoplastic agents in clinical treatment facilities, and
is a known human carcinogen (Larson, Khazaeli, & Dillon, 2003).
Generally, the occupational activities that pose the greatest risk of exposure are the
preparation and administration of antineoplastic agents, cleaning of chemotherapy spills,
and handling of patient excreta (Martin & Larson, 2003). Agencies such as the Oncology
Nursing Society have developed guidelines for the safe handling of hazardous drugs
because of the potential dangers they present. These guidelines are recommendations that
are intended to improve the routine involved with the pr^aration and administration of
chemotherapy. Thus, the problem statement that was generated for the scope of this
investigation concerns the role of the healthcare provider in facilitating risk surveillance
of occupational exposure to antineoplastic agents.
Statem ent o f Purpose
Exposure risk and its relationship to healthcare professionals’ compliance to
established protocols for the safe handling and administration of chemotherapy agents
continues to be a concern for healthcare institutions (Ritchie, McAdams, & Fritz, 2000).
Studies of healthcare workers have shown that chemotherapy drugs have caused acute
adverse effects such as nausea, headache and dizziness (Valanis, Vollmer, Labuhn, &
Glass, 1997). Other potential long-term adverse reactions documented in the literature

related to occupational exposure to antineoplastics include chromosomal aberrations and
adverse reproductive outcomes. Currently, there does not exist sufficient research to
explain why some healthcare workers do not follow recommended precautions (Ritchie et
al, 2000). Future nursing research should focus on assessing and identifying ways to
increase awareness and encourage compliance.
Significance o f the S tu ^
The current level of healthcare knowledge regarding the role of the healthcare
provider in facilitating risk surveillance of occupational exposure to antineoplastic agents
is limited. A computer search utilizing CINAHL, MEDLINE, and Cochrane Library,
revealed only several articles on this subject. Terms utilized in the search included the
following;
Table 1
Sumnuny ofIJterature Searches
Search Terms

Number of Citations

Database

nurs* and risk surveillance

1

CINAHL

2

MEDLINE

31

COCHRANE

1002

CINAHL

1202

MEDLINE

35

COCHRANE

29

CINAHL

30

MEDLINE

nurs* and occupational exposure

nurs* and chemotherapy agents

nurs* and antineoplastic agents

risk surveillance and occupational

34

COCHRANE

930

CINAHL

1639

MEDLINE

7

COCHRANE

0

CINAHL

exposure
MEDLINE
COCHRANE
nurse practitioner and Becker

risk surveillance and Becker

occupational exposure and Becker

0

CINAHL

6

MEDLINE

11

COCHRANE

0

CINAHL

0

MEDLINE

7

COCHRANE

0

CINAHL

41

MEDLINE
COCHRANE

Note, CINAHL ~ Cumulative Index to Nursing and Allied Health Literature, MEDLINE
= Medical Literature Online, COCHRANE = Cochrane Library (Cochrane Database of
Systematic Review, Cochrane Database of Abstracts of Reviews of Evidence, and
Cochrane Clinical Trials Register).
Clinical significance regarding the role of the healthcare provider in facilitating
risk surveillance of occupational exposure to antineoplastic agents is focused on the need
for cost-effective, high-quality care. In spite of the medical benefits resulting from the
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use of these drugs, they may be potentially harmful to workers handling them. Adverse
health effects from both acute and chronic exposures have been demonstrated in
healthcare personnel. In 1979, the British journal. Lancet, published a report suggesting
that healthcare personnel handling antineoplastic agents may be at risk. This study by
Falck et al. (1979) showed mutagenic activity in the urine of nurses working in an
oncology unit, and proposed that the cause was related to exposure to antineoplastic
agents. This was the first look at the carcinogenic risk of antineoplastics from an
occupational standpoint. The clinical significance regarding the occupational exposure
risks associated with antineoplastic use is tremendous.
Theoretical Foundation
The Health Belief Model (HBM) and its extended form, the Protection Motivation
Theory (PMT) state that the adoption of a behavior appropriate to the prevention or
control of some disease depends on the individual’s perception of a threat to personal
health and a conviction that the recommended action will reduce this threat (Floyd,
Prentice-Dunn, & Rogers, 2000). The Protection Motivation Theory has been used in
many studies that attempt to explain why behavioral choices are made, thus is an
appropriate theoretical framework for this study. The perception of a health threat is
determined by the strength of two underlying beliefs: personal susceptibility to a given
disease and the potential severity of its impact on the individual’s life. These perceptions
can be awakened or strengthened through a striking event. The perceived efficacy of the
recommended preventive action depends on a personal assessment of the perceived
benefits of the proposed behavior and real or perceived barriers to initiation or
continuation of the suggested behavior. The Protection Motivation Theory assumes that
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anticipation of a negative health outcome and the desire to avoid this outcome or reduce
its impact creates motivation for self-protection (Rogers, 1983). And that intent to change
behavior is generated only when the benefits outweigh the costs associated with making
the change.
According to the PMT, a maladaptive response like not using protective
equipment is facilitated by certain rewards. For example, nurses’ can quickly prepare and
administer the chemo without having to adorn all sorts of protective equipment. This
translates into less time patients have to wait. The maladaptive response is also inhibited
by the perceived severity of exposure risk and nurses’ perceived vulnerability to it. In the
PMT, anxiety has no direct relation with behavioral intention or behavior, but is mediated
by perceived vulnerability, which is seen as a cognitive representation of anxiety (Floyd,
Prentice-Dunn, & Rogers, 2000). Adaptive responses, such using personal protective
equipment is, according to the model, facilitated by response efficacy and self-efficacy.
In this context, response efficacy refers to the belief that using protective equipment
reduces the risks of exposure. Self-efficacy refers to the perceived ability to perform
these behaviors consistently. While it cannot predict the amount of behavior change that
will occur following an intervention. Protection Motivation Theory can predict whether
some groups more than others will benefit from interventions based on the theory
(Rogers, 1983). The Protection Motivation Theory has been used in many studies that
attempt to explain why behavioral choices are made, thus is an appropriate theoretical
framework for this study.
Definition o f Terms
For the purposes of this study, the following terms are defined:

Risk SurvdUance
Theoretical Life is a risky business and deciding which risks are worth taking
and which should be avoided has important implications for an individual’s lifestyle. The
benefits gained fi*om taking a risk need to be weighed against the possible disadvantages.
Different people have a different level of preference for taking risks. Some people go
bungee-jumping in their free time while others prefer to read. Demographic variables
have a large effect on risk propensity. For example, males have a higher risk inclination
than females; older people have a lower risk inclination than younger people; different
cultures endorse different risk-taking values; and person with more depmdents will tend
to take fewer risks (Lipshitz, Klein, Orasanu, & Salas, 2001).
Risk perception also depends on experience. An inexperienced decision-maker
will perceive lower risk, and as a result, might often take greater risks than desirable.
Also, because his or her decision is based on only a small sample of past decisions and
outcomes, it is likely that an additional piece of information might cause him or her to
change the decision (Lipshitz et al., 2001). A moderately experienced decision-maker
sees all the risks involved and is not as likely to be affected by additional information,
since he or she has more to experience to base the decision on. Just like the moderately
experienced decision-maker, the expert knows about all the risks; however, because of
his or her past experience, the expert might be overconfident and again perceive the risks
as lower than they actually are, potentially leading to overconfidence. Lastly, risk
perception is affected by perceived responsibility for the outcome: people will regard as
more risky situations that they have frill responsibility. Therefore, many people try to
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limit their personal responsibility for risky outcomes by discussing the decision with
their superiors or their team.
Operational Research shows that people tend to overestimate the probability of
unfamiliar, catastrophic and well-publicized events and to underestimate the probability
of unspectacular or familiar events (Lipshitz et al., 2001). Misperception of risk can lead
to unreasonable concern about a hazard. Given a chance, people would rather not have to
confront the risks inherent in life’s activities. Psychological research shows that
whenever possible, people attempt to reduce the anxiety generated in the face of
uncertainty by denying that uncertainties, thus making the risk seem either so small that it
can safely be ignored or so large that it clearly should be avoided. They are
uncomfortable when given statements of probability rather than fact; they want to know
exactly what will happen. The general public’s perceptions of risk are often highly
inaccurate, but by underestimating common risks while exaggerating exotic ones, we
may end up protecting ourselves against the unlikely perils while failing to take
precautions against those that are far more dangerous.
Occupational Ejqfosure
Theoretical Occupational exposure is the reasonably anticipated skin, eye,
mucous membrane, or parenteral contact with blood or other potentially hazardous
materials that may result from the performance of an employee's duties. Occupational
exposure to hazardous drugs and the resulting potential health risk to healthcare workers
first became a recognized safety concern in the 1970s. Traditional assumptions about safe
drug handling were challenged by a study published in a recent edition of the American
Journal of Health-System Pharmacy. This study confirmed that, despite existing
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protective measures, there persists widespread surface contamination with antineoplastic
drugs in the workplace and employee e?q)Osure to carcinogenic or mutagenic particulates
and vapors.
The inadvertent introduction of hazardous drugs into an environment can occur in
various ways. Drug containers may become damaged in the shipping process. A broken,
cracked, or otherwise damaged container may result in leakage of the hazardous materials
onto other containers. If not properly inspected upon receipt, the shipping container can
be opened in the receiving area, exposing receiving personnel to the hazardous agent. In
addition, contamination of the surrounding drug storage areas may occur. The
manipulation required to prepare hazardous drugs for administration may also lead to
environmental contamination. Leaks, spills, and the creation of aerosols of liquid drugs
can occur during dose preparation. The process of priming IV tubing may lead to
inadvertent environmental contamination if the priming process is not performed
appropriately. In addition, during drug administration, tubing and injection port
connections that are not properly secured may lead to leakage of the prepared agent.
Inappropriate disposal of hazardous drugs, either from the clean-up of spills or leaks, or
from waste created during drug preparation and administration, can also lead to
environmental contamination.
Operational Mutagenic changes in the urine and evidence of chromosome
damage in healthcare personnel who have prepared or administered antineoplastic drugs
led to the conclusion that handling such drugs poses a genuine health risk to the
individuals involved. Because these measures were indirect, and a direct cause-and-effect
relationship could not be determined, more direct methods of determining exposure have
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been developed. These methods include urinalysis to determine the presence of
metabolites o f dangerous drugs handled by healthcare workers, and environmental air and
surfece sampling techniques
Antineoplastic Agents
Theoretical These agents are chemotherapy drugs that modify the growth and
reproduction of cancer cells through alteration of the genetic material thereby destroying
them. Despite the medical benefits of these drugs, they may be potentially harmful to
workers handling them. Many chemotherapeutic drugs are known human carcinogens, for
which there is no safe level o f exposure. Falck et al. (1979) were the first to note
evidence of mutagenicity in the urine of nurses who handled cytotoxic drugs. Researchers
have also studied pharmacy personnel who handled antineoplastic drugs. The researchers
showed increasingly mutagenic urine over the period of exposure; when they stopped
handling the drugs, activity fell within 2 days to the level of unexposed controls (Nguyen,
Theiss, & Matney, 1982). The researchers also found mutagenicity in workers using
horizontal laminar flow hoods that decreased to control levels with the use of vertical
flow containment hoods.
Operational Generally, the occupational activities that pose the greatest risk of
exposure are the preparation and administration of antineoplastic agents, cleaning of
chemotherapy spills, and handling of patient excreta (Martin & Larson, 2003). The
Occupational Safety & Health Administration has created guidelines to control
occupational exposure to hazardous drugs like the cytotoxic agents used in cancer
treatment facilities. Safe levels of exposure have not been determined therefore; it is
essential to minimize exposure to these agents.
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The guidelines recommends that chemotherapy preparation be performed in a
restricted, preferably, centralized area (OSHA, 1999). Signs restricting the access of
unauthorized personnel are to be prominently displayed. Eating, drinking, smoking,
chewing gum, applying cosmetics, and storing food in the preparation area should be
prohibited. OSHA also recommends that procedures for spills and emergencies, such as
skin or eye contact be posted in this area. The use of class II or HI Biological Safety
Cabinets should minimize exposure during preparation. Decontamination of the hood
should be performed routinely and serviced by a qualified technician at least every six
months.
Research indicates that the thickness of the gloves used in handling
antineoplastics is more important than the type of material, since all materials tested have
been found to be permeable to some agents (Singleton & Connor, 1999). Because all
gloves are permeable to some extent and their permeability increases with time, they
should be changed regularly (hourly) or immediately if they are tom, punctured, or
contaminated with a spill (OSHA, 1999).
A protective disposable gown made of lint-free, low-permeability fabric with a
closed front, long sleeves, and elastic or knit closed cuffs should be worn (OSHA, 1999).
The cuffs should be tucked under the gloves. Eye and face protective equipment should
be worn whenever splashes, sprays, or aerosols of chemo may be generated. All gowns,
gloves, and disposable materials used in preparation should be disposed of according to
the hospital's hazardous dmg waste procedures and as described under this review's
section on waste disposal. Goggles, face shields and respirators may be cleaned with mild
detergent and water for reuse.
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Findings from e^dsting research indicate that compliance with established
safety guidelines offers adequate protection to those healthcare workers involved in the
handling, administration, and care of patients receiving chemotherapy agents (Ritchie,
McAdams, & Fritz, 2000). Despite the adoption of these guidelines in healthcare
institutions, reports in the current literature suggest that some workers do not follow the
standards established by their employers and current OSHA guidelines, putting
themselves at risk for exposure to potential mutagenicity, alterations in fertility and long
term effects from chemotherapy agents (Valanis, Vollmer, Labuhn, & Glass, 1997),
Valanis, McNeil, and Driscoll (1991) found like results among staff members’ adherence
to fecility protocol regarding the handling of cytotoxic agents. Ben-Ami, Shaham, Rabin,
and Ribak (2001) showed that notwithstanding the rules and regulations pertaining to
cytotoxic drugs, nurses in the study did not comply to them fully. The safety behavior of
exposed nurses and the relative usage of safety equipment were related to their appraisal
of their susceptibility to becoming ill.
Nurses have given a number of reasons for not wearing protective equipment
when handling cytotoxic drugs (Valanis, McNeil, & Driscoll, 1991). Barriers to using the
protective equipment include that it is inconvenient to wear, time-consuming and
awkward to apply, and not readily available (Mahon, Casperson, Yackzan, Goodner,
Hasse, Hawkins et al., 1994). Other barriers include a lack of awareness of the health
risks of handling cytotoxic drugs, disbelief that a danger actually exists despite being
informed, and a concern that wearing the protective equipment may upset the patient
(Mahon et al., 1994).
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Research Questions
For the purposes of this study, the following research questions were generated:
1. What is the level of healthcare knowledge regarding the role of the healthcare
provider in facilitating risk surveillance of occupational exposure to antineoplastic
agents?
2. According to the literature, how can healthcare providers contribute to costeffective, high-quality care by facilitating risk surveillance of occupational
hazards?
3. According to the literature, how can healthcare providers contribute to costeffective, high-quality care by facilitating risk surveillance of exposure to
antineoplastic agents?
Delimitations
Literature was delimited, for the purpose of this integrative literature review, to the
following:
1. Literature that pertains to the role of the healthcare provider in facilitating risk
surveillance of occupational exposure to antineoplastic agents.
2. Literature that is available in the English language or translated into English
abstracts.
3. Literature available through CINAHL, MEDLINE, and Cochrane Libraries.
4. Literature that is available through the Mississippi University for Women Library
and Interlibrary loan program.
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LimiUUions
For the purpose of this investigation a particular limitation identified is that the
information obtained cannot be generalized beyond the scope of the research reviewed.
The generalizability of the findings is further impacted by the lack of nursing research
related to the role of the healthcare provider in facilitating risk surveillance of
occupational exposure to antineoplastic agents.
Sunmuuy
The oncogenic and teratogenic effects of antineoplastic agents are well
established. However, the long term effects of continued exposure to small amounts of
one or more of such drugs remain undetermined. For example, it is known that long-term
use of potent immunosuppressive agents may result in the development of lymphoma. It
is not known, however, at what drug level or over what period of time this may occur and
how this correlates with possible drug levels achieved through occupational exposure
during preparation and administration of hundreds or thousands of injectable and oral
doses of these agents.
The danger to healthcare personnel firom handling hazardous drugs stems fi*om a
combination of its inherent toxicity and the extent to which workers are exposed to the
drug in the course of carrying out their duties. This exposure may be through inadvertent
ingestion of the drug on foodstuffs (e.g., workers’ lunches), inhalation of drug dusts or
droplets, or direct skin contact. Preventing Occupational Exposures to Antineoplastic and
Other Hazardous Drugs in Healthcare Settings was recently published by NIOSH
(DHHS Publication Number 2004-165). The purpose of this release was to increase
awareness among healthcare workers and their employers about the health risks posed by
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working with hazardous drugs and to provide them with measures to protect their
health.

To date, the research provides primary evidence that healthcare workers

exposed to hazardous drugs during the course of their work are absorbing these drugs and
are at risk for adverse outcomes.
Additional research in this area is needed, but awareness of the problem has led to
overall reduction of e?q)osures, either by improved drug handling techniques or through
the implementation of safety programs and thus fewer exposed healthcare workers are
available for study. Definitive knowledge of the occupational dangers of handling
hazardous drugs may someday be available through epidemiologic studies of healthcare
workers.
In theory, correct and perfect preparation and handling techniques will prevent
drug particles or droplets from escaping from their containers while they are being
manipulated. Near-perfect technique is uncommon; therefore, contamination of the
workplace is likely and worker exposure may increase without protective equipment and
other safety measures. This is particularly true in the absence of any structured training
and quality-assurance programs covering the proper handling of hazardous drugs.

CHAPTER n
Review of Literature
This investigation is an integrative literature review which summarizes research
on a topic of interest by placing the research problem in context and identifying gaps and
weaknesses in prior studies to justify new investigations (Polit & Beck, 2004). For the
purpose of this investigation, data-based and theory-based manuscripts were reviewed
and critiqued using a knowledgebase template concerning occupational exposure to
antineoplastic agents (see Appendix A). Literature reviewed totaled six data-based
manuscripts and three theory-based manuscripts, which represented reviews of another
one-hundred thirty references. In this chapter, an overview of the study variables is
presented as it has emerged from the developing knowledgebase.
An Overview o f the Healthcare Literature Related to Risk Surveillance
o f Occupational E ra su re to Antineoplastic Agents
According to a study by Brown (2000), that was indexed in MEDLINE, a number
of pertinent conclusions were made concerning antineoplastic agents and occupational
exposure. The data-based method was that of a descriptive design with a sample
(#=126). A strength of the study was that the researchers employed genetic testing to
validate chromosomal deviations resultant to occupational exposure to antineoplastic
agent use among oncology nurses in a selected cancer clinic on the East coast. A
weakness of the research was that generalizability of findings was limited due to the
homogenous sample of convenience. The research does provide a foundation for fiirther
study in this area; however, the convenience sampling used in the study may impact
external validity. Results suggest that exposure to antineoplastic is a potential health
16

17

hazard. Findings suggest that exposure be kept to a minimum and the use protective
measures are essential when handling antineoplastics.
In a study by Burgaz et al., 2002), that was conducted in Turkey and indexed in
MEDLINE, conclusions concerning antineoplastic drugs, chromosomal aberrations, and
nurse occupational exposure were reported. The data-based method was that o f a
descriptive design with a large sample (#=738). The study showed that increased genetic
damage was directly a result of occupational exposure to antineoplastic agents. A
weakness of the design was that only one antineoplastic agent, cyclophosphamide, was
reviewed in relationship to occupational exposure. The study reveals a need to research
the concept and domains with other antineoplastic agents. In addition, lengthy written
questionnaires can be source of error as subjects tire of questions and completes survey
too quickly. However, the large sample does provide a foundation for future research in
this area. O f concern was the fact that a questionnaire was used to assess previous
personnel exposure to cyclophosphamide. Accuracy of such data collection remains
unclear, relying heavily on recollection. Analyses of CP in urine demonstrated compound
absorption. Also, higher CP excretion rates were observed among nurses handling CP,
suggesting a direct relation between handling CP and occupational exposure to CP.
Increased frequency of structural CA in peripheral lymphocytes is associated with an
increased overall risk for cancer. This warrants chromosomal changes to be regarded as
potentially serious effects. Exposure to these genotoxic chemicals should be limited. This
study also showed that increased genetic damage was evident in nurses at the population
level due to occupational exposure to antineoplastics. Results suggest that exposure be
kept to a minimum and protective measures are essential when handling antineoplastics.
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Also emphasized was the importance of the establishment and implementation of
national regulations for handling these substances.
In a literature review by Gribben (2002), indexed in CINAHL, the concepts of
antineoplastic agents, occupational exposure, and protective equipment were explored.
The data-based manuscript followed the pattern of a systematic literature review. A
strength of the study was that it examined factors influencing use of personal protective
equipment and the development of acute adverse health effects. A weakness of the
findings was that terms were not well-defined, which may obfuscate the author’s
intended meaning. The systematic review provides the foundation for further research.
The lack of clarity in literature selection may be a source of potential bias influencing the
findings. This article examined the use o f personal protective equipment and adverse
health effects associated with antineoplastic use. Findings indicate that the use of gloves,
mask, and goggles have a significant effect on reducing the likelihood of adverse health
outcomes associated with antineoplastic use. In addition, diligent preparation of the drugs
under a biological safety cabinet greatly reduces the potential for adverse health effects.
Results suggest that exposure be kept to a minimum and protective measures are essential
when handling antineoplastics. Also emphasized was the importance of the establishment
and implementation of national regulations for handling these substances.
In a research study conducted by Larson and Khazeli (2003), indexed in
MEDLINE, conclusion were reported regarding research of antineoplastics and air
monitoring methods. The data-based method was that of a descriptive design. Strengths
of the research is that it explored a variety of filter monitoring methods for
antineoplastics. Data collection and analysis were done concurrently thereby reducing the
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risk of miscoding or other analysis errors. A weakness of the study is that preparation
of standards were obtained but could not always be verified by the analysis of blank or
spiked samples. The conclusions of the study provide a foundation for further research in
this area. A threat to the study was that the potential for cyclophosphamide to sublimate
off filter material may account for potential skewed findings. This study addressed the
issue of overall effectiveness of current monitoring media for antineoplastics. In addition,
the study also looked at solid sorbent médias as a method of choice. Indications fi"om the
study include the finding that filter methods are not acceptable for air monitoring of
cyclophosphamide and possibly other antineoplastic agents. This information also
supports the observation that the HEPA filter is not an acceptable control for biological
safety cabinets that return filtered air to the work room.
In a study by Rodgers (2000), that was indexed in MEDLINE, variables
concerning pharmacy personnel, antineoplastic agents, and occupational exposure were
explored. The data-based method was that of a descriptive design in a considerable
sample (N =348). A strength of the research was the extensive descriptive survey of
personnel exposure to antineoplastics and use of personal protective equipment.
However, a weakness of the design was that lengthy, written questionnaires can be source
of error as subjects tire of questions and completes survey too quickly. Moreover, nurses
who fear their answer would exemplify them as ignorant or indifferent may not have
answered truthfidly. The research provides a foundation for further study exploring these
variables. A threat to the study was the potential for skewed findings since risk is
subjective in nature. Moreover, the subject may not reveal true feelings to avoid being
labeled as indifferent or uncaring which could alter the validity of the findings. This
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study looked at nurse perception of risk associated with antineoplastic use and
examined the nurse’s demographics in relation to the use of personal; protective
equipment. The study revealed that the use of personal protection was statistically
significant in regards to the demographic variables which were defined for the study.
In a research study conducted by Sardas, Gok and Karakaya (2003), that was
conducted in Turkey and indexed in MEDLINE, variables explored included:
antineoplastic drugs, chromosome damage, and occupational exposure. The data-based
method was that of a quasi-experimental design (n=23 nurses; n=50 control). A strength
of the research was that this study examined a group of 23 oncology nurses working in
different university hospitals in Turkey with a control group of 50 unexposed individuals.
However, the lack of standardized microscope slide preparation could potentially skew
test results. Even so, the research provides the foundation for future exploration of these
variables. A threat to the study was that several slides did not demonstrate any
relationship between occupational exposure to antineoplastics and increased sister
chromatid exchanges. This article examines the increase in sister chromatid exchanges in
circulating lymphocytes among nurses handling antineoplastic agents. This work has also
shown that cigarette smoking causes a significant increase in SCE’s. Overall, this study
supports the existence of an association between professional exposure to antineoplastic
drugs and an increase in SCE’s in lymphocytes and that smoking contributes to elevated
SCE rates.
In a study by Thompson (2004), that was indexed in MEDLINE, the variables of
hazardous chemicals, antineoplastic agents, and occupational exposure were explored.
The data-based method was that of a descriptive design in a large sample (#=421). A
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strength of the study was that the authors stressed the fact that antineoplastic use is
appropriate and beneficial to patients experiencing a terminal disease such as cancer.
However, there is significant risk for adverse health effects from occupational exposure.
A weakness of the design was that the sample size was limited to members of Oncology
Nursing Society. This study validated previous research that workplace exposure to
antineoplastics is potential health risk. Adverse outcomes are associated highly with the
extent of exposure as well as the toxicity o f the drugs. However, the homogenous sample
of convenience limits the ability to generalize the findings to other nurses without
membership in ONS. This study looked at personnel exposure to antineoplastic agents in
the workplace. Findings indicate the potential exists for adverse health effects with the
use of these drugs. Further research should involve the deliberate sampling of diverse
populations as well as the use of personal protective equipment to decrease the chances of
risk.
In a research study conducted by Valanis, Vollmer, Labuhn, and Glass (2001),
that was indexed in MEDLINE, the variables of antineoplastic agents, absorption, and
toxicity were explored. The data-based method used was that of a descriptive design in a
large sample (#=800), A strength of the study was that the setting included large medical
centers where data was easily accessible. A weakness of the study was the lack of clarity
in method may mask internal threats to validity and reliability of findings. Results of the
study provide foundation for friture research regarding acute adverse effects. A threat to
the study was the volunteer-based sample and moderate participation rates are clear
limitations-sample essentially protected group. This study looked at the relationship
between occupational exposure to antineoplastic drugs and the presence of acute
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symptoms of exposure. Handling of these drugs was associated with a significant
increase in the number of symptoms compared with controls. Skin contact was the most
predominant predictor of symptoms. The number of doses and extent of protection were
significantly associated with the number of symptoms as well.
Summary
In reviewing the literature, it was determined that a consensus among the
researchers exists regarding the feet that the drugs are cytotoxic and have the potential for
causing adverse health effects, both short-term and long-term. Research supported the
notion that three variables have emerged as being best predictors of adverse effects.
These variables include: duration of exposure, toxicity of the drug, and use of personal
protective gear. An fwea of disagreement among the researchers was found regarding the
degree to which personal protective equipment was found to be effective. Moreover,
current research regarding antineoplastic monitoring methods was found to be less
effective than originally expected. An interesting finding of the literature review was the
notion that complacency in working with such drugs, can kill. For healthcare providers,
the importance of screening for occupational exposure is critical. Moreover, in
occupational health environments, the importance of a pre-employment screening and
regular screenings thereafter is essential.

CHAPTER m
Design and Methodology
This chapter will present the parameters used for this research investigation. The
approach that was used was that of an evidence-based systematic review. According to
Sackett, Straus, Richardson, Rosenberg, and Haynes (2000) evidence-based practice
attempts to integrate best research evidence with clinical expertise and patient values.
The literature selection procedure and literature analysis procedure is detailed in this
chapter.
Approach
An integrated literature review, which is a review of research that amasses
comprehensive information on a topic, weighs pieces of evidence, and integrates
information to draw conclusions about the state of knowledge, will be used for this study.
This investigation is an evidence-based practice systematic review. While an integrative
literature review summarizes research on a topic of interest, by placing the research
problem in context and identifying gaps and weaknesses in prior studies to justify the
new investigation (Polit & Beck, 2004), evidence-based practice seeks to integrate best
research evidence with clinical expertise and patient values (Sackett, Straus, Richardson,
Rosenberg, & Haynes, 2000). A summary of the current literature regarding the role of
the healthcare provider in facilitating risk surveillance of occupational exposure to
antineoplastic agents is provided.
Literature Selection Procedure
A systematic search of CINAHL, MEDLINE, and the Cochrane Library was
conducted for the relevant literature concerning the role of the healthcare provider in
23
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facilitating risk surveillance of occupational exposure to antineoplastic agents. The
reference list accompanying each article was then manually reviewed for fiirther articles
pertaining to the subject. Articles were selected based on inclusion of at least one of the
relevant concepts, whether as the focus of the article or as part of a broader topic. Other
informative articles were also included to fiirther explore the knowledgebase.
The systematic review of the literature began with CINAHL to find relevant
nursing literature on the role of the healthcare provider in facilitating risk surveillance of
occupational exposure to antineoplastic agents. Next, MEDLINE and then the Cochrane
Library were evaluated for further relevant literature. Journal articles were obtained
through the Mississippi University for Women library, via Internet databases and
interlibrary loan. The review incorporated data beyond nursing literature to expand the
knowledgebase for a thorough review, thus providing a multi-disciplinary approach.
References utilized were relevant and applicable to this investigation. The
references were obtained from reputable and respected scholarly journals in the
healthcare fields. The evidence-based practice procedure (Sackett, et al., 2000) for the
systematic review comprises the following steps:
1. convert the need for information (about prevention, diagnosis, prognosis,
therapy, causation, etc.) into research questions.
2. track down the best evidence with which to answer the questions using a
variety of database strategies.
3. critically appraise the evidence for its validity (closeness to the truth), impact
(size of the effect), and applicability (usefulness in our clinical practice
addressing both sensitivity and specificity).
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4. integrate the critical appraisal with clinical expertise and the patient’s
unique biology, values and circumstances (p. 3-4).
Literature Analysis Procedure
For the purpose of this study, a knowledgebase of literature critiques will be used
to organize the literature by source and date, variables of interest, literature type and
research tools, research design and sample size, theoretical foundation, references, and
key findings. Data (provided in Appendix A) is analyzed in terms of relevancy of
findings and then summarized utilizing a chart format to assist in application of findings
to the clinical problem. The findings document the current state of knowledge available
that is discussed in Chapter Four according to the research questions regarding the role of
the healthcare provider in facilitating risk surveillance of occupational exposure to
antineoplastic agents.
Sununary
This chapter detailed the parameters for this research investigation. This
evidence-based practice systematic review of the literature will be conducted utilizing the
literature selection procedure and literature analysis procedure highlighted above.
Through this process, the research questions regarding the role of the healthcare provider
in facilitating risk surveillance of occupational exposure to antineoplastic agents,
will be answered.

CHAPTER IV
Knowledgebase Findings and Practice-Based Application
The purpose of this section is to expound the findings of the knowledgebase
derived fi*om this evidenced-based systemic literature review. Tables showing pertinent
findings fi*om of this knowledgebase are provided with practice-based applications fi-om
current clinical practice guidelines.
Knowledgebase Findings
In order to obtain the knowledgebase findings, a systematic literature search of
CINAHL, MEDLINE, and the Cochrane Library was conducted by this author. The
literature reviewed totaled 8 citations, which represented another 122 references.
Findings fi*om the literature reviewed are addressed in this section in terms of each
research question generated for the scope of this study.
Research Question One
Research question one asks: What is the level of healthcare knowledge regarding
the role of the healthcare provider in facilitating risk surveillance of occupational
exposure to antineoplastic agents? The results of this literature review reflect the growing
knowledge of the risks associated with exposure to antineoplastic drugs, as well as the
development and application of policies aimed at preventing occupational exposure of
nurses to these drugs. Healthcare professionals think of antineoplastic drugs in terms of
their therapeutic value to cancer patients. However, there’s a risk of serious health
problems for healthcare workers who are occupationally exposed to such agents.
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Table 2
Characteristics o f Citations Reviewed
Citation

Type

Database

Brown, 2000

Data-based (descriptive)

MEDLINE

Burgaz et al., 2002

Data-based (descriptive)

MEDLINE

Gribben, 2002

Data-based (systematic

CINAHL

literature review)
Larson & Khazeli, 2003

Data-based (descriptive)

MEDLINE

Rodgers, 2000

Data-based (descriptive)

MEDLINE

Sardas, Gok & Karakaya, 2003

Data-based (quasi-

MEDLINE

experimental)
Thompson, 2004

Data-based (descriptive)

MEDLINE

Valanis, Vollmer, Labuhn, & Glass,

Data-based (descriptive)

MEDLINE

2001
Note, Total number of citations reviewed = 8.
Research Question Two
Research question two asks; According to the literature, how can healthcare
providers contribute to cost-effective, high-quality care by facilitating risk surveillance of
occupational hazards? Studies have demonstrated widespread environmental
contamination by hazardous drugs in preparation and administration areas, as well as
human uptake. Healthcare providers can facilitate the delivery of high-quality healthcare
to oncology patients by complying with current standards and recommendations set forth
by agencies such as OSHA, Research suggests the use of personal protective equipment
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and diligent drug preparation reduce the likelihood of an occupational hazard.
Nonetheless, workplace exposures should be immediately reported, the events
meticulously documented, and any injuries treated without delay.
Research Question Three
Research question three asks: According to the literature, how can healthcare
providers contribute to cost-effective, high-quality care by facilitating risk surveillance of
exposure to antineoplastic agents? Hazardous drugs are drugs that pose a potential health
risk to healthcare workers who may be exposed during preparation or administration.
Such drugs require special handling because of their inherent toxicities. The health and
safety of workers who handle hazardous drugs should be a high priority. Medical
monitoring and risk surveillance programs enhance the safety and overall wellbeing of
the healthcare providers.
Practice-Based Application
In order to obtain the practice-based findings, a search for clinical practice
guidelines housed in the world wide web (WWW) was conducted by this author. The
web revealed a number of sites with clinical practice guideline holdings including the
Centers for Disease Control and the Agency for Healthcare Research and Quality.
Clinical practice guideline findings fi*om the web holdings are addressed in this section in
terms of each research question generated for the scope of this study.
Research Question One
Research question one asks: What is the level of healthcare knowledge regarding
the role of the healthcare provider in facilitating risk surveillance of occupational
exposure to antineoplastic agents? The clinical practice guidelines concerning
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occupational exposure to antineoplastic agents according to NIOSH (CDC, 2004),
acknowledges some important practices. The carcinogenicity of several antineoplastic
drugs has been well established. A number o f studies indicate that antineoplastic drugs
may cause increased genotoxic effects in pharmacists and nurses exposed in the
workplace (Falck et al., 1979; Valanis, Vollmer, Labuhn, & Glass, 2001). Several studies
that have not linked genotoxic effects with worker exposures may be explained by
technical confounders and a lack of accurate blood and urine sampling in exposed
workers. The weight of evidence associates hazardous drug exposures at work with
increased genotoxicity. Curr^tly no recommended exposure limits have been
established. Recommended guidelines and standards have been created to keep exposure
and risk at a minimum.
Table 3
Sumnuay o f Ciinical Practice Guidelines Reviewed
Source of Guidelines

Website URL

Agency for Healthcare Research and Quality

www.ahra.sov

Centers for Disease Control and Prevention

www.cdc.2ov/niosh/docs/2004-165/

Occupational Safety and Health Administration

www.osha.20v

Oncology Nursing Society

www.ons.ors

Note, Total number of guidelines reviewed = 3.
Research Question Two
Research question two asks. According to the literature, how can healthcare
providers contribute to cost-effective, high-quality care by facilitating risk surveillance of
occupational hazards? High-quality, cost-effective care for the oncology patient is
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important. Employee medical surveillance is an additional strategy for optimizing the
health status of persons who work in settings where hazards exist. Medical risk
surveillance involves a carefiil search for unexpected outcomes that might herald new or
uncontrolled hazards in the workplace. It most often refers to the systematic collection,
analysis and dissemination of health information on groups of workers. For risk
surveillance to be an effective warning mechanism, it must be connected to preventive
safety and health actions. Healthcare providers overseeing the surveillance effort must
take the lead in ensuring that quality issues relating to medical screening and surveillance
are adequately addressed. This step is important because when otherwise healthy persons
are screened, end points of significance are usually more subtle than they are in overtly
symptomatic persons. Adhering to available guidelines also facilitates epidemiologic
review because of the quality and integrity of the data obtained.
Research Question Three
Research question three asks: According to the literature, how can healthcare
providers contribute to cost-effective, high-quality care by facilitating risk surveillance of
exposure to antineoplastic agents? Occupational exposure to anticancer drugs has been
shown to be associated with both increased incidence of malignancy in male and female
healthcare workers, as well as fetal developmental effects in their offspring (Valanis et
al., 2001). It is therefore essential for oncology nurses to be aware of the potential effects
of cytotoxic agents, and diligent in taking the steps needed to minimize exposure. Several
studies have documented the surface contamination that can occur throughout the
healthcare setting. Examination of work practices is important to reduce exposure. Data
indicate that exposure is lower than in the past, but also that cleaning techniques remain
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inefficient, that ineffective surface cleaning can result in spreading contamination, and
that surface contamination can and does result in worker contamination.
Summary
The purpose of this investigation was to explore the literature regarding the
current level o f healthcare knowledge regarding the role of the healthcare provider in
facilitating risk surveillance of occupational exposure to antineoplastic agents. The
results of this investigation suggest that occupational exposure to cytotoxic substances
continues to be a hazard in the healthcare setting; however, the literature did not provide
consistent significant findings to prove a relationship between occupational exposure and
mutagenesis. The three major variables in determining severity of exposure include
duration of exposure, toxicity of the drug, and the use of personal protective equipment.
It is essential for oncology nurses to understand the risk of hazardous drug exposure in all
areas of the healthcare setting, and to ensure careful and proper work practices—such as
using appropriate BSC techniques, changing gloves fi^equently, swabbing final products,
and using appropriate drug cleaning and inactivation agents—to reduce the risk of
exposure for themselves and their colleagues.

CHAPTER V
Evidence-Based Conclusions, Implications, and Recommendations
The potential adverse health risks from occupational exposure to hazardous drugs
are based on the inherent toxicities of the drugs. The same health effects that occur in
patients who receive therapeutic doses of the drugs are possible if employees are
exposed. Hazardous drugs are genotoxic, carcinogenic, teratogenic or cause
developmental toxicity. Many result in adverse reproductive outcomes and cause organ
toxicity at low doses.
Evidence for continued risk of occupational exposure to antineoplastic agents is
abundant; however, nurses' use of the recommended precautions is not universal. This
may be related to a lack of information or to a lack of serious concern for the potential
hazards, there was little interest or concern among health care workers. Information about
health effects from low levels of occupational exposure is sparse in recent literature.
Many reports of adverse effects were published before the implementation of safe
handling precautions. This has contributed to the lack of concern among nurses regarding
hazardous drug handling. Hazardous drug handling is potentially risky work. Many
nurses have the potential to be exposed to hazardous drugs in the workplace.
OSHA, ASHP, ONS, and NIOSH all provide guidelines for the safe handling of
hazardous drugs. While not providing complete protection, it is believed that adherence
to current recommendations will reduce health care workers’ exposure. By reducing
exposure, the negative health effects should be reduced. It is time for nurses to take their
own occupational safety as seriously as the safety of the patients under their care.
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Summary o f the Investigation
This literature review was undertaken with the focus of exploring the available
literature regarding the current level of healthcare knowledge regarding the role o f the
healthcare provider in fecilitating risk surveillance of occupational exposure to
antineoplastic agents. A review of the literature revealed the need to fiirther the level of
knowledge regarding this issue. This chapter provides a summary of the literature review,
including interpretation o f the findings and the conclusions drawn fi-om the findings, as
well as limitations of the study and recommendations for further research.
Interpretation o f Findings with Conclusions
According to the literature analysis, the findings fi*om this investigation
demonstrate a consensus in the literature regarding the current level o f healthcare
knowledge regarding the role of the healthcare provider in facilitating risk surveillance of
occupational exposure to antineoplastic agents. An examination of the literature revealed
that this area requires further investigation. Conclusions drawn fi-om the findings reveal
that healthcare providers are often well aware of the drug’s potential toxicity; however
they disregard recommended national guidelines set forth. In tins section, the
interpretation of the findings will be presented in response to each research question.
Research Question One
The first research question asked, “What is the level o f healthcare knowledge
regarding the role of the healthcare provider in facilitating risk surveillance of
occupational exposure to antineoplastic agents?” The results of the research indicate the
level of healthcare knowledge regarding the role of the healthcare provider in facilitating
risk surveillance of occupational exposure to antineoplastic agents is limited. Much has
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been written about securing caregivers' compliance with practice guidelines and other
best practice recommendations. However, it appears that defining ideal practices may be
easier than getting clinicians to change their long-established habits. Caregivers seem to
resist change even when it's the right thing to do. For example, in a study of how well
oncology nurses comply with OSHA guidelines for handling cytotoxic drugs, researchers
found that some of the nurses used some protective equipment when preparing and
administering cytotoxic drugs, but the type of equipment and its fi*equency of use did not
specifically meet OSHA guidelines (Gribben, 2002).
Research Question Two
The second research question asked, “According to the literature, how can
healthcare providers contribute to cost-effective, high-quality care by facilitating risk
surveillance of occupational hazards?” The results of the research indicate that costeffective, high-quality care is enhanced by facilitating risk surveillance of occupational
hazards. Moreover, facilitating risk surveillance of occupational hazards was addressed in
the knowledgebase in that authors agreed that risk surveillance was important, but not
necessarily conducted fi*om the perspective of occupational hazard exposure.
Conversely, facilitating risk surveillance of occupational hazards was addressed in the
clinical guidelines reviewed in that guidelines posted by various agencies stressed the
importance and method, but differed dramatically in content and process. The consensus
was that healthcare providers should implement surveillance efforts and take the lead in
ensuring that quality issues relating to risk surveillance are adequately addressed.

35

Research Question Three
Research question three asks: According to the literature, how can healthcare
providers contribute to cost-effective, high-quality care by facilitating risk surveillance of
exposure to antineoplastic agents? The results of the research indicate that cost-effective,
high-quality care is enhanced by facilitating risk surveillance of exposure to
antineoplastic agents. Moreover, facilitating risk surveillance of exposure to
antineoplastic agents was addressed in the knowledgebase in that authors agreed that risk
surveillance was important, but not necessarily conducted from the perspective of
antineoplastic agent exposure. Conversely, facilitating risk surveillance of exposure to
antineoplastic agents was addressed in the clinical guidelines reviewed in that guidelines
posted by various agencies stressed the importance and method, but differed dramatically
in content and process. The consensus was that healthcare providers should implement
surveillance efforts and take the lead in ensuring that quality issues relating to risk
surveillance are adequately addressed.
Limitations
There were limitations identified in this study. Some information obtained cannot
be generalized beyond the scope of the research that was reviewed. Also, lengthy written
questionnaires can be source of error as subjects’ tire of questions and completes survey
too quickly. Most of the research was limited to specific populations and locations,
therefore findings may not prove reliable when tested in other locations or with other
populations.
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Implications and Recommendations
The review of the literature revealed limited documentation regarding the level of
healthcare knowledge regarding the role of the healthcare provider in facilitating risk
surveillance of occupational exposure to antineoplastic agents. There was agreement that
duration of exposure, toxicity of drug, and use of personal protective equipment directly
affect exposure risk. Gribben (2002) showed that use and availability of personal
protective equipment when handling chemotherapy have increased, but medical
monitoring of exposed employees still is neither widely practiced nor consistent with
OSHA guidelines.
Safety concerns and potential adverse health effects associated with the
occupational handling of chemotherapeutic agents have been reported. Historically,
nurses' adherence to chemotherapy-handling guidelines has been poor. Results suggest
that adherence is increasing. The investigation of the literature has resulted in
implications and recommendations focused on nursing theory, nursing research,
advanced nursing practice, nurse practitioner education, and health policy. Each o f these
areas will be considered in this section.
Nursing Theory
The theoretical foundation for this study was Becker’s Protection Motivation
Theory. Although primarily not a nursing theory, it has been used in many studies that
attempt to explain why behavioral choices are made, thus is an appropriate theoretical
framework for this study.
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Nursing Research
The level o f healthcare knowledge regarding risk surveillance of occupational
exposure to antineoplastic agents is very scant. Safety concerns and potential adverse
health effects associated with the occupational handling of chemotherapeutic agents have
been reported. Historically, nurses' adherence to chemotherapy-handling guidelines has
been poor. Results suggest that adherence is increasing; however, research is lacking
regarding nurses' level of knowledge of and specific barriers to safe handling of
chemotherapy. Although adherence to recommended guidelines is increasing, further
research regarding specific barriers to safe handling of chemotherapy is needed.
Research empowers practice and enhances the status of nursing as a profession by
expanding nursing’s scientific knowledgebase. Research findings not only improve
patient care but also affect the healthcare system (Polit & Beck, 2004).
Advanced Nursing Practice
Oncology nurses are key professionals in the delivery of skilled care to people
with cancer. These nurses are challenged with the responsibility of coordinating quality
patient care and administering chemotherapy. The administration of chemotherapeutic
agents is an integral part of nurses’ role in the provision of care. Cytostatic drugs possess
toxic properties and may cause mutagenic, carcinogenic and teratogenic effects.
Therefore, nurses handling these drugs in the course of their profession may face serious
health risks. The occupational exposure risk of cytotoxic agents was first documented in
health care personnel by Falck et al. (1979) who reported an elevated frequency of
mutagenesis in spot urines after continuous low-level exposure within a group of
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oncology nurses. Proper handling of these drugs combined with the use of personal
protective equipment can drastically reduce this threat.
Nurse PractiHoner Education
In nursing, there is an emphasis on providing competent, safe nursing care to
enhance patient safety. However, intertwined in the promotion o f safe patient care is the
critical issue of nurse safety. Nurse Practitioners are renowned for their superb
communication and educating ability. As a result, they should promote healthcare
provider safety in relation to antineoplastic handling as well.
Health Policy
As a result of the recent trend toward managed care, it has become essential for
healthcare providers to consider cost-effective, high-quality strategies in providing care
for oncology patients. The oncology Nurse Practitioner must assume a leadership role in
promoting risk surveillance programs through education, legislation, and social policy
change.
Summary
According to Martin and Larson (2003), healthcare professionals involved with
handling antineoplastic drugs may be exposed inadvertently to these agents, placing them
at potential risk for acute and long-term adverse effects. For example, cyclophosphamide
one of the most frequently used antineoplastic agents in clinical treatment facilities, is a
known human carcinogen (Larson, Khazaeli, & Dillon, 2003). While the health risks
associated with cytotoxic use have been well established, there is little information
available about how people perceive these risks, particularly among those most affected
by it-chemotherapy nurses. Therefore, the purpose of this Evidence Based Practice (EBP)
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project was to develop a nurse practitioner knowledgebase regarding the impact o f risk
perception on the cytotoxic agent safety behaviors of oncology nurses. The research
questions asked: (a) what is the level of healthcare knowledge regarding the role o f the
healthcare provider in facilitating risk surveillance of occupational exposure to
antineoplastic agents? (b) according to the literature, how can healthcare providers
contribute to cost-effective, high-quality care by facilitating risk surveillance of
occupational hazards? and (c) according to the literature, how can healthcare providers
contribute to cost-effective, high-quality care by facilitating risk surveillance of exposure
to antmeoplastic agents? A Boolean computer search of nursing and medical literature
for theory-based, data-based, randomized controlled trials for citations utilizing
CINAHL, MEDLINE, and the Cochrane Library was conducted for this systematic
review.
Becker’s Health Belief Model (1974) served as the theoretical foundation for this
clinical project and guided the systematic review through data collection of the healthcare
literature. Literature reviewed totaled 21 manuscripts, which represented reviews of
another 419 references. Studies of healthcare workers have shown that occupational
exposure to antineoplastic agents has caused acute adverse effects such as nausea,
headache and dizziness (Valanis, Vollmer, Labuhn, and Glass, 1997). Exposure risk and
its relationship to healthcare professionals’ compliance to established protocols for the
safe handling and administration of chemotherapy agents continues to be a concern for
health care institutions (Ritchie, McAdams, and Fritz, 2000). The literature reviewed for
this study recommends compliance with established safety guidelines to ensure adequate
protection to those involved in the handling, administration, and care of patients receiving
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antineoplastic agents. Yet despite the adoption of these guidelines in healthcare
institutions, the current literature also suggests that many workers do not follow the
standards established by their employers and current OSHA guidelines, putting
themselves at risk for exposure to potential mutagenicity, alterations in fertility and long
term effects from chemotherapy agents (Valanis, Vollmer, Labuhn, and Glass, 1997).
Using an Evidence Based Medicine (EBM) approach, based on that of Sackett,
Straus, Richardson, Rosenberg, and Haynes (2000), a knowledgebase was developed
according to methods described by Davidson (2003) in which key findings from the
systematic review of randomized control trials, data-based and theory-based literature
were compared with current practice guidelines, resulting in a number of safe practice
recommendations. These recommendations emphasize that safe levels o f exposure to
antineoplastic agents have not been determined therefore; it is essential to minimize
exposure.
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